HMGN3

high mobility group nucleosomal binding domain 3, the group of Canonical high mobility group

Basic information

Region (hg38): 6:79201245-79234689

Previous symbols: [ "TRIP7" ]

Links

ENSG00000118418NCBI:9324OMIM:604502HGNC:12312Uniprot:Q15651AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HMGN3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HMGN3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
1
clinvar
1
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 0 1 0

Variants in HMGN3

This is a list of pathogenic ClinVar variants found in the HMGN3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-79201695-C-T not specified Uncertain significance (Jan 14, 2025)3858163
6-79201724-T-C not specified Likely benign (May 21, 2024)3284501
6-79202122-T-C not specified Likely benign (Mar 06, 2023)2465130
6-79202142-C-T not specified Uncertain significance (Jul 27, 2022)2404441
6-79202313-G-C not specified Uncertain significance (Dec 19, 2022)2336875
6-79202352-C-T not specified Uncertain significance (Jan 09, 2025)3858162
6-79203623-G-A not specified Uncertain significance (Mar 07, 2023)2456098
6-79208548-G-A not specified Uncertain significance (Jan 06, 2023)3106286
6-79208548-G-C not specified Uncertain significance (Apr 13, 2023)2510208
6-79214995-C-T not specified Uncertain significance (Feb 23, 2023)2459689

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HMGN3protein_codingprotein_codingENST00000344726 633445
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.05780.874125725071257320.0000278
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7613651.40.7010.00000251631
Missense in Polyphen1822.3020.80711288
Synonymous0.3191516.70.9018.10e-7182
Loss of Function1.5337.520.3993.14e-7104

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002900.0000290
Ashkenazi Jewish0.000.00
East Asian0.00005600.0000544
Finnish0.00004620.0000462
European (Non-Finnish)0.00003530.0000352
Middle Eastern0.00005600.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds to nucleosomes, regulating chromatin structure and consequently, chromatin-dependent processes such as transcription, DNA replication and DNA repair. Affects both insulin and glucagon levels and modulates the expression of pancreatic genes involved in insulin secretion. Regulates the expression of the glucose transporter SLC2A2 by binding specifically to its promoter region and recruiting PDX1 and additional transcription factors. Regulates the expression of SLC6A9, a glycine transporter which regulates the glycine concentration in synaptic junctions in the central nervous system, by binding to its transcription start site. May play a role in ocular development and astrocyte function (By similarity). {ECO:0000250}.;

Recessive Scores

pRec
0.163

Intolerance Scores

loftool
0.366
rvis_EVS
0.08
rvis_percentile_EVS
59.43

Haploinsufficiency Scores

pHI
0.350
hipred
N
hipred_score
0.332
ghis
0.637

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hmgn3
Phenotype
homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
chromatin organization;biological_process;positive regulation of transcription by RNA polymerase II;regulation of insulin secretion involved in cellular response to glucose stimulus
Cellular component
chromatin;nucleoplasm;cytosol
Molecular function
nucleosomal DNA binding;thyroid hormone receptor binding